Table 3.
Study | Study Design | Number of prticipants | Age group | Intervention | Follow-up |
City/ Country |
NYHA |
---|---|---|---|---|---|---|---|
Piotrowicz et al.2010 [35] | Prospective randomized trial | 152 | Aged 58.1 + 10.2 years | Home-based vs SCR | 8 weeks after randomization | Warsaw, Poland |
Yes Class II or III |
Karapolat et al. 2009 [36] | Randomized control trial | 74 |
Home-based: 45.16 ± 13.58 Hospital-based: 44.05 ± 11.49 |
Home-based vs hospital-based | 8 weeks after randomization | Izmir, Turkey |
Yes Class II or III |
Ma et al.2022 [37] | A prospective randomized controlled trial | 136 |
Intervention group: 64.18 ± 8.70 Control group: 63.56 ± 8.29 |
Home-based vs community Care | 24 weeks after randomization | Guangzhou, southern China |
Yes Class I, II and III |
Nagatomi et al. 2022 [38] | Single-center, open-label, randomized, controlled trial | 30 | 63.7 ± 10.1 years | Home-based vs standard care | 3 months after randomization | Fukuoka, Japan |
Yes Class I, II and III |
Chen et al. 2018 [39] | Randomized prospective trial | 37 |
Control group: 60 ± 16 Intervention group: 61 ± 11 |
Home-based vs standard medical care | 3 months after randomization | Taichung, Taiwan |
Yes Not specified |
Frost et al. 2019 [40] |
Multicenter randomized controlled trial |
216 |
Intervention group: 69.7 ± 10.9 Control group: 68.5 ± 9.8 |
REACH-HF + usual Care vs usual Care | 12 months after randomization |
Four geographical regions (Birmingham, Cornwall, Gwent and York) across the UK |
Yes Class II or III |
Peng et al. 2018 [41] | Prospective, randomized control trial | 98 |
Years≤60 = 30.6% Years> 60 = 69.4% |
Home-based telehealth exercise training program vs usual care | 4 months after randomization | Chengdu, Republic of China |
Yes Class I, II and III |
Piotrowicz et al. 2015 [42] | Single-center, prospective, parallel-group, randomized (2:1), controlled trial | 111 |
Intervention group: 54.4 ± 10.9 Control group: 62.1 ± 12.5 |
Home-based telemonitored NW vs usual Care |
8 weeks after randomization | Warsaw, Poland |
Yes Class II and III |
Dalal et al. 2019 [43] |
Multicenter, two parallel group, randomized, superiority trial |
216 |
Intervention group: 69.7 ± 10.9 Control group: 69.9 ± 11 |
REACH-HF vs usual care | 12 months after randomization |
Four centers in the United Kingdom (Birmingham, Cornwall, Gwent and York) |
Yes Class I, II, III and IV |
Safiyari-Hafizi et al. 2016 [44] | Randomized control trial | 40 | < 75 years | HBCR vs usual care | 12 weeks after randomization | British Columbia, Canada |
Yes Not specified |
Piotrowicz et al. 2019 [45] |
Prospective randomized controlled trial |
131 | 56.4 ± 10.9 | Home-based telemonitored cardiac rehabilitation vs standard cardiac rehabilitation | 8 weeks after randomization | Warsaw, Poland |
Yes Class II and III |